Q2 Holdings (QTWO) Insider Sale Under 10b5-1 Plan Leaves 17,792 Shares
Rhea-AI Filing Summary
James Offerdahl, a director of Q2 Holdings, Inc. (QTWO), reported the sale of 786 shares of common stock on 08/12/2025 at a price of $74.15 per share. The Form 4 states the transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2025. Following the sale, Mr. Offerdahl beneficially owns 17,792 shares held directly. No derivative securities are reported. The filing was signed by an attorney-in-fact on 08/13/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine insider sale reported under a pre-established 10b5-1 plan; small reduction in direct holdings.
The Form 4 discloses a single non-derivative sale of 786 common shares by director James Offerdahl on 08/12/2025 at $74.15 per share. The filing explicitly states the sale was executed pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2025, and shows 17,792 shares remain beneficially owned directly. For corporate governance review this is a standard disclosure: the sale is documented and executed under an established plan and the Form 4 lists an attorney-in-fact signature.
TL;DR Insiders sold a small block of stock under a documented plan; the transaction is disclosed cleanly on Form 4.
The reported transaction is a non-derivative disposition of 786 shares, leaving 17,792 shares held directly. The sale price of $74.15 and the Rule 10b5-1 plan adoption date of May 13, 2025 are provided on the form. No options, warrants, or other derivative instruments are disclosed. The clean Form 4 filing and attorney-in-fact signature indicate procedural compliance; the filing contains no additional material items that would materially change an investor’s view based solely on this document.